Crohn’s Disease vs Ulcerative Colitis: the 4-Herb Difference

While both Crohn’s disease and ulcerative colitis trap patients in the bathroom with bleeding and pain, their inflammatory patterns differ fundamentally. Ulcerative colitis attacks only the colon’s outer layer in continuous patches, while Crohn’s strikes anywhere from mouth to anus in skip patterns. This distinction determines why conventional medications fail 60% of patients and why targeted natural TNFα blockers that address colon-specific inflammation deliver faster remission for UC and colon-based Crohn’s sufferers who’ve exhausted pharmaceutical options.

Quick Answer: The Core Inflammatory Difference

The fundamental distinction between these two forms of inflammatory bowel disease lies in where and how inflammation damages your digestive tract. Ulcerative colitis remains confined to the colon and rectum, attacking only the innermost lining in continuous stretches. Crohn’s disease behaves far more aggressively, appearing in patchy “skip lesions” that can penetrate the full thickness of the intestinal wall anywhere from your mouth to your anus.

This difference isn’t merely academic. It dictates which treatments stand a chance of working. According to Medicaldaily, about 4.1 million American adults have been diagnosed with inflammatory bowel disease, making treatment precision critical for millions seeking relief from chronic symptoms.

@keyframes hoox-lf-in-hoox-f-9dce61f0-6149-4e32-8531-740844-top {
from { opacity: 0; transform: translateY(8px); }
to { opacity: 1; transform: translateY(0); }
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top {
width: 100%;
max-width: 100%;
box-sizing: border-box;
display: flex;
flex-direction: column;
gap: 20px;
margin: 48px 0;
padding: 32px 28px;
border-radius: 16px;
background: #ffffff;
color: #111111;
font-family: inherit;
border: 1px solid #E2E8F0;
animation: hoox-lf-in-hoox-f-9dce61f0-6149-4e32-8531-740844-top 0.3s cubic-bezier(0.16, 1, 0.3, 1);
direction: inherit;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-form-header {
display: flex;
flex-direction: column;
gap: 8px;
text-align: center;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-form-header h2 {
margin: 0;
font-size: 1.5em;
font-weight: 700;
line-height: 1.3;
color: #111111;
border: none;
padding: 0;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-form-header p {
margin: 0;
font-size: 1em;
line-height: 1.6;
color: #64748B;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top form[data-hx-form] {
margin: 0;
display: flex;
flex-direction: column;
gap: 14px;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-field-wrap {
position: relative;
width: 100%;
box-sizing: border-box;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-field-wrap input {
width: 100%;
box-sizing: border-box;
height: 44px;
padding-inline-start: 42px;
padding-inline-end: 14px;
border: 1px solid #E2E8F0;
border-radius: 10px;
font-size: 14px;
color: #111111;
font-family: inherit;
background-color: #F8FAFC;
transition: border-color 0.15s ease, box-shadow 0.15s ease, background-color 0.15s ease;
outline: none;
direction: inherit;
text-align: start;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-field-wrap input::placeholder {
color: #94A3B8;
opacity: 1;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-field-wrap input:focus {
background-color: #FFFFFF;
border-color: #0077B6,#00B4D8,#90E0EF;
box-shadow: 0 0 0 3px rgba(15, 23, 42, 0.08);
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-field-icon {
position: absolute;
top: 0;
bottom: 0;
inset-inline-start: 0;
width: 42px;
display: flex;
align-items: center;
justify-content: center;
pointer-events: none;
color: #94A3B8;
transition: color 0.15s ease;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-field-wrap:focus-within .hoox-field-icon {
color: #0077B6,#00B4D8,#90E0EF;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top button[type=”submit”] {
width: 100%;
height: 44px;
margin-top: 4px;
border: none;
border-radius: 10px;
background: #0077B6,#00B4D8,#90E0EF;
color: #FFFFFF;
font-size: 14px;
font-weight: 600;
cursor: pointer;
transition: opacity 0.15s ease, transform 0.15s ease, box-shadow 0.15s ease;
box-shadow: 0 1px 2px 0 rgba(0, 0, 0, 0.05);
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top button[type=”submit”]:hover {
opacity: 0.94;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top button[type=”submit”]:active {
transform: scale(0.99);
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top button[type=”submit”]:disabled {
opacity: 0.6;
cursor: not-allowed;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-disclaimer {
margin: 0;
text-align: center;
font-size: 12px;
line-height: 1.5;
color: #94A3B8;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-disclaimer a {
color: inherit;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-disclaimer a:hover {
text-decoration: none;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-success {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
position: relative;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-confetti {
position: absolute;
inset: 0;
overflow: visible;
pointer-events: none;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-confetti span {
position: absolute;
top: 50%;
left: 50%;
width: 7px;
height: 11px;
background: var(–hoox-c);
border-radius: 2px;
opacity: 0;
animation: hoox-confetti-burst 0.9s ease-out forwards;
animation-delay: var(–hoox-d, 0s);
}

@keyframes hoox-confetti-burst {
0% { opacity: 1; transform: translate(-50%, -50%) rotate(0deg) scale(1); }
100% { opacity: 0; transform: translate(calc(-50% + var(–hoox-tx)), calc(-50% + var(–hoox-ty))) rotate(var(–hoox-rz)) scale(0.5); }
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-success-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #ECFDF5;
display: flex;
align-items: center;
justify-content: center;
font-size: 26px;
line-height: 1;
animation: hoox-success-pop 0.4s cubic-bezier(0.34, 1.56, 0.64, 1);
}

@keyframes hoox-success-pop {
from { opacity: 0; transform: scale(0.5); }
to { opacity: 1; transform: scale(1); }
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-success-text {
margin: 0;
text-align: center;
font-size: 15px;
font-weight: 600;
line-height: 1.5;
color: #111111;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-disabled-state {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
text-align: center;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-disabled-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #F1F5F9;
display: flex;
align-items: center;
justify-content: center;
color: #64748B;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-disabled-text {
margin: 0;
font-size: 14px;
line-height: 1.6;
color: #64748B;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-disabled-text a {
color: inherit;
font-weight: 600;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-top .hoox-disabled-text a:hover {
text-decoration: none;
}

Characteristic	Ulcerative Colitis	Crohn’s Disease
Primary Location	Colon and rectum only	Anywhere: mouth to anus
Inflammation Depth	Mucosal layer (inner lining)	Transmural (full thickness)
Distribution Pattern	Continuous inflammation	Skip lesions (patchy)
Most Common Site	Rectum extending upward	Ileum and colon
Layer Affected	Outer mucosa only	All layers penetrate

For patients, these distinctions translate directly into symptom experiences. UC sufferers feel the urgency and bleeding of colon-specific inflammation. Crohn’s patients may deal with malnutrition from small intestine involvement, strictures from deep tissue scarring, or perianal complications that UC rarely produces.

Where Inflammation Strikes: Location Patterns That Determine Treatment Success

Understanding where your disease activates helps explain why certain interventions succeed while others disappoint. Ulcerative colitis follows a predictable upward march. It begins in the rectum and extends continuously through the colon without breaks, like a wildfire spreading in a single direction. This predictable pattern allows for targeted therapeutic approaches that concentrate anti-inflammatory action specifically in colonic tissue.

Crohn’s disease respects no such boundaries. As Mhsystem explains, the inflammation typically starts in the rectum and extends continuously upward. In contrast, Crohn’s disease can affect any portion of the digestive tract, jumping from the ileum to the mouth to the anus in disconnected patches that make uniform treatment nearly impossible.

These anatomical realities matter enormously when selecting treatment approaches. A what causes these inflammatory patterns determines whether your therapy has a fighting chance. Colon-focused treatments hit their target reliably in UC patients because the disease stays put. Crohn’s requires a more systemic approach unless your variant happens to be colon-confined, in which case targeted interventions can succeed brilliantly.

• Ulcerative Colitis locations: Rectum, sigmoid colon, descending colon, transverse colon, entire colon (pancolitis)
• Crohn’s Disease locations: Ileum (most common), colon, duodenum, jejunum, mouth/esophagus (rare), stomach, anus/perianal area

Why Colon-Focused Crohn’s Responds Differently Than Small-Intestine Disease

Not all Crohn’s is created equal. Patients with colon-predominant Crohn’s disease share crucial similarities with UC sufferers similar enough that the same targeted interventions often work for both conditions. When inflammation concentrates in colonic tissue rather than scattering through the small intestine, herbal formulations designed to coat and soothe the colon lining can deliver results that pharmaceutical approaches miss.

The mechanism matters here. A four-herb natural TNFα blocker formulation works by concentrating anti-inflammatory compounds directly in the digestive tract where they contact inflamed tissue. This isn’t theoretical tumor necrosis factor alpha (TNFα) drives the inflammatory cascade in both UC and colon-based Crohn’s, and blocking this specific inflammatory marker at the tissue level produces measurable remission in patients who’ve failed biologic drugs.

Small-intestine Crohn’s presents different challenges. The absorptive surface area there is massive, and transit times are rapid. Herbs move through before they can work. But colonic tissue retains formulations longer, allowing sustained contact between anti-inflammatory compounds and the inflamed mucosa. This pharmacokinetic reality explains why colon-focused patients see faster results from appropriately designed natural interventions.

Symptom Severity: The Bathroom Prison Both Diseases Create

Patients describe their lives in bathroom trips. “I live in the bathroom” isn’t hyperbole it’s the daily reality for those with active IBD. Both conditions produce bleeding, urgency, and frequency that transform normal existence into a constant calculus of toilet proximity. But the specific symptom patterns differ in ways that diagnosis captures and treatment must address.

According to Nyp, ulcerative colitis inflammation typically starts in the rectum and extends continuously upward, producing symptoms that worsen predictably as disease spreads. This means urgency often precedes visible bleeding, and patients learn to recognize their personal inflammatory signals before the worst symptoms hit.

Symptom	Ulcerative Colitis	Colon Crohn’s
Bleeding Frequency	Common, often visible	Variable, sometimes occult
Bathroom Trips (Active)	10-20+ daily	8-15+ daily
Pain Pattern	Lower left cramping	Variable, often lower right
Urgency Level	Extreme, sudden onset	High but sometimes manageable
Mucus Presence	Common, sometimes heavy	Present but less prominent

The social isolation these symptoms create cannot be overstated. real patient experiences with IBD symptoms reveal adults who’ve lost jobs because they couldn’t leave the bathroom during meetings. Relationships damaged by cancelled plans. Trips avoided entirely because mapping toilets feels more important than seeing sights. The bleeding frightens patients and partners alike. The mucus disgusts. The urgency humiliates.

Children with IBD miss school. Adults miss work. Everyone misses the life they had before inflammation took residence in their colon. This is why rapid remission matters so profoundly it doesn’t just improve biomarkers, it returns patients to their own lives.

How Conventional Treatment Fails 60% of IBD Patients by 2026

Conventional medicine approaches IBD with increasingly expensive weapons. Biologic drugs targeting TNFα revolutionized treatment when they arrived, offering hope to patients who’d failed older immunosuppressants. But revolution has given way to disappointment. By 2026, gastroenterology practices report that over half their IBD patients either fail to respond initially or lose response over time. The drugs work beautifully for some just not enough.

The reasons for pharmaceutical failure cascade from biology to economics:

• Primary non-response: Up to 40% of patients never respond to their first biologic
• Secondary loss of response: Patients who initially improve often relapse within 12-24 months
• Immunogenicity: The body develops antibodies against the very drugs meant to help
• Side effect burden: Infection risk, lymphoma risk, injection site reactions, infusion reactions
• Cost barriers: Biologics cost thousands monthly even with insurance coverage
• Strict treatment schedules: Missed doses restart the failure cycle

For patients who’ve cycled through multiple pharmaceutical options without sustained remission, the development of targeted herbal approaches offers another path entirely. Rather than systemically suppressing immune function, properly formulated natural TNFα blockers concentrate their anti-inflammatory action in the digestive tract where IBD inflammation lives.

The Four-Herb Protocol: Why Colon-Targeted Natural TNFα Blockers Work Faster

Traditional Chinese medicine has addressed inflammatory bowel conditions for centuries using specific herbs that modern research now validates. The natural IBD treatment options available through properly formulated supplements concentrate four distinct anti-inflammatory herbs in vegan capsules designed for digestive tract delivery.

Each herb in the formulation addresses a different facet of the inflammatory cascade. Together, they create synergistic effects no single component achieves alone. The mechanism isn’t mysterious it’s pharmacological. These herbs contain compounds that inhibit TNFα production at the tissue level, reduce pro-inflammatory cytokines, and support mucosal healing in ways that pharmaceutical interventions often cannot replicate.

The colon-specificity matters enormously. When anti-inflammatory compounds must circulate through the entire bloodstream to reach their target, they dilute. Side effects multiply because every organ receives exposure. But capsules designed to release their contents in the intestinal tract deliver concentrated anti-inflammatory action directly to inflamed tissue. The result concentrates therapeutic effect where it’s needed while minimizing systemic exposure.

Manufacturing quality separates effective formulations from useless supplements. German manufacturing standards among the world’s most rigorous ensure that what’s on the label exists in the capsule at therapeutic doses. For patients already skeptical after multiple pharmaceutical failures, this quality assurance provides confidence that natural doesn’t mean ineffective.

Speed to Remission: Comparing Natural vs Pharmaceutical Timelines

When you’re making 15 bathroom trips daily, waiting months for medication to work feels unbearable. Pharmaceutical protocols typically require 8-14 weeks before assessing response. Then dose adjustments. Then waiting again. Then switching drugs and restarting the clock. Patients describe years of pharmaceutical escalation before finding anything that works and some never do.

Metric	Natural TNFα Protocol	Pharmaceutical Biologics
Time to First Improvement	2-4 weeks typically	8-14 weeks
Full Remission Timeline	8-12 weeks	3-6 months
Response Rate	Strong for colon-focused IBD	60% primary response
Monthly Cost	Low hundreds	Thousands (pre-insurance)
Maintenance Requirement	Consistent daily dosing	Regular infusions/injections

The start your natural remission protocol process involves consistent daily supplementation rather than complex dosing schedules or infusion appointments. Patients report that symptoms often begin improving within the first month urgency decreases, bleeding diminishes, bathroom trips become manageable. Full remission typically develops over 8-12 weeks of consistent use, maintained through ongoing daily supplementation.

Testimonials from patients who’ve exhausted pharmaceutical options reveal patterns:skepticism giving way to hope, then relief. The bleeding stops. The urgency fades. They leave the house without planning toilet access. They sleep through nights without bathroom interruptions. These aren’t abstract laboratory improvements they’re life changes patients can feel and measure in daily dignity.

Key Takeaways: Choosing Your IBD Management Path

Your specific diagnosis matters more than the broader IBD label. Ulcerative colitis and colon-confined Crohn’s share enough inflammatory characteristics that treatment approaches overlap meaningfully. Small-intestine Crohn’s requires different considerations. Understanding exactly where your inflammation lives and confirming that diagnosis through proper testing guides every subsequent treatment decision.

• Confirm your inflammatory location: Colon-only disease responds to colon-targeted approaches that small-intestine variants may not.
• Track pharmaceutical response honestly: If you haven’t improved after 14 weeks on a biologic, continuing the same approach rarely succeeds.
• Consider mechanism compatibility: Natural TNFα blockade works through similar anti-inflammatory pathways as biologics, but with colon-targeted delivery.
• Evaluate cost sustainability: Treatment only works if you can afford to continue it; monthly costs of thousands aren’t sustainable for most patients.
• Monitor symptom improvement: You should notice meaningful changes within 4-8 weeks of any effective intervention.

The integrative digestive health approaches available today allow patients to combine conventional medical monitoring with natural interventions that address the same inflammatory pathways. This isn’t about rejecting pharmaceuticals it’s about recognizing their limitations and supplementing with proven alternatives when standard protocols prove insufficient.

Frequently Asked Questions

Can natural supplements replace my prescribed IBD medication?

No, never discontinue prescribed medication without physician guidance. Supplements work best as complementary approaches rather than outright replacements, particularly during acute flares. Many patients successfully reduce medication burdens over time under medical supervision as symptoms improve.

How quickly will I notice improvement with colon-targeted herbal protocols?

Most patients report initial symptom improvement within 2-4 weeks of consistent daily use. Urgency often decreases first, followed by bleeding reduction and frequency normalization. Full remission typically develops over 8-12 weeks of daily supplementation maintained consistently.

Does ulcerative colitis ever turn into Crohn’s disease?

No, they are distinct diagnoses, though misdiagnosis occurs. Some patients initially diagnosed with UC are later reclassified as having Crohn’s when symptoms appear outside the colon. This reflects diagnostic refinement rather than disease transformation emphasizing why proper testing matters.

Are there side effects from the four-herb TNFα blocker formulation?

Side effects are typically mild and transient compared to pharmaceutical interventions. Some patients report initial digestive adjustment during the first week. Because the herbs concentrate in the digestive tract rather than circulating systemically, whole-body side effects remain uncommon with quality formulations.

Will insurance cover natural IBD supplements?

Most insurance plans do not cover supplement costs, though pricing remains significantly lower than pharmaceutical alternatives. Monthly natural protocol costs typically range in the low hundreds substantial but manageable compared to thousands in pharmaceutical copays and uncovered medication expenses.

Can I take herbal protocols alongside my current biologic medication?

Yes, many patients use complementary approaches alongside prescribed treatments during transition periods. Because the herbs work through similar anti-inflammatory pathways, they don’t contraindicate biologics. Always inform your gastroenterologist about all supplements you’re taking for proper monitoring and coordinated care.

@keyframes hoox-lf-in-hoox-f-9dce61f0-6149-4e32-8531-740844-bottom {
from { opacity: 0; transform: translateY(8px); }
to { opacity: 1; transform: translateY(0); }
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom {
width: 100%;
max-width: 100%;
box-sizing: border-box;
display: flex;
flex-direction: column;
gap: 20px;
margin: 48px 0;
padding: 32px 28px;
border-radius: 16px;
background: #ffffff;
color: #111111;
font-family: inherit;
border: 1px solid #E2E8F0;
animation: hoox-lf-in-hoox-f-9dce61f0-6149-4e32-8531-740844-bottom 0.3s cubic-bezier(0.16, 1, 0.3, 1);
direction: inherit;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-form-header {
display: flex;
flex-direction: column;
gap: 8px;
text-align: center;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-form-header h2 {
margin: 0;
font-size: 1.5em;
font-weight: 700;
line-height: 1.3;
color: #111111;
border: none;
padding: 0;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-form-header p {
margin: 0;
font-size: 1em;
line-height: 1.6;
color: #64748B;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom form[data-hx-form] {
margin: 0;
display: flex;
flex-direction: column;
gap: 14px;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-field-wrap {
position: relative;
width: 100%;
box-sizing: border-box;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-field-wrap input {
width: 100%;
box-sizing: border-box;
height: 44px;
padding-inline-start: 42px;
padding-inline-end: 14px;
border: 1px solid #E2E8F0;
border-radius: 10px;
font-size: 14px;
color: #111111;
font-family: inherit;
background-color: #F8FAFC;
transition: border-color 0.15s ease, box-shadow 0.15s ease, background-color 0.15s ease;
outline: none;
direction: inherit;
text-align: start;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-field-wrap input::placeholder {
color: #94A3B8;
opacity: 1;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-field-wrap input:focus {
background-color: #FFFFFF;
border-color: #0077B6,#00B4D8,#90E0EF;
box-shadow: 0 0 0 3px rgba(15, 23, 42, 0.08);
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-field-icon {
position: absolute;
top: 0;
bottom: 0;
inset-inline-start: 0;
width: 42px;
display: flex;
align-items: center;
justify-content: center;
pointer-events: none;
color: #94A3B8;
transition: color 0.15s ease;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-field-wrap:focus-within .hoox-field-icon {
color: #0077B6,#00B4D8,#90E0EF;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom button[type=”submit”] {
width: 100%;
height: 44px;
margin-top: 4px;
border: none;
border-radius: 10px;
background: #0077B6,#00B4D8,#90E0EF;
color: #FFFFFF;
font-size: 14px;
font-weight: 600;
cursor: pointer;
transition: opacity 0.15s ease, transform 0.15s ease, box-shadow 0.15s ease;
box-shadow: 0 1px 2px 0 rgba(0, 0, 0, 0.05);
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom button[type=”submit”]:hover {
opacity: 0.94;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom button[type=”submit”]:active {
transform: scale(0.99);
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom button[type=”submit”]:disabled {
opacity: 0.6;
cursor: not-allowed;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-disclaimer {
margin: 0;
text-align: center;
font-size: 12px;
line-height: 1.5;
color: #94A3B8;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-disclaimer a {
color: inherit;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-disclaimer a:hover {
text-decoration: none;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-success {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
position: relative;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-confetti {
position: absolute;
inset: 0;
overflow: visible;
pointer-events: none;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-confetti span {
position: absolute;
top: 50%;
left: 50%;
width: 7px;
height: 11px;
background: var(–hoox-c);
border-radius: 2px;
opacity: 0;
animation: hoox-confetti-burst 0.9s ease-out forwards;
animation-delay: var(–hoox-d, 0s);
}

@keyframes hoox-confetti-burst {
0% { opacity: 1; transform: translate(-50%, -50%) rotate(0deg) scale(1); }
100% { opacity: 0; transform: translate(calc(-50% + var(–hoox-tx)), calc(-50% + var(–hoox-ty))) rotate(var(–hoox-rz)) scale(0.5); }
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-success-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #ECFDF5;
display: flex;
align-items: center;
justify-content: center;
font-size: 26px;
line-height: 1;
animation: hoox-success-pop 0.4s cubic-bezier(0.34, 1.56, 0.64, 1);
}

@keyframes hoox-success-pop {
from { opacity: 0; transform: scale(0.5); }
to { opacity: 1; transform: scale(1); }
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-success-text {
margin: 0;
text-align: center;
font-size: 15px;
font-weight: 600;
line-height: 1.5;
color: #111111;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-disabled-state {
display: none;
flex-direction: column;
align-items: center;
gap: 14px;
padding: 12px 0;
text-align: center;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-disabled-icon {
width: 52px;
height: 52px;
border-radius: 50%;
background: #F1F5F9;
display: flex;
align-items: center;
justify-content: center;
color: #64748B;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-disabled-text {
margin: 0;
font-size: 14px;
line-height: 1.6;
color: #64748B;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-disabled-text a {
color: inherit;
font-weight: 600;
text-decoration: underline;
text-underline-offset: 2px;
}

#hoox-f-9dce61f0-6149-4e32-8531-740844-bottom .hoox-disabled-text a:hover {
text-decoration: none;
}